Antigen-Binding Molecule Having Regulated Conjugation Between Heavy-Chain And Light-Chain - EP2787078

The patent EP2787078 was granted to Chugai Seiyaku Kabushiki Kaisha on May 22, 2019. The application was originally filed on Oct 31, 2012 under application number EP12846665A. The patent is currently recorded with a legal status of "Revoked".

EP2787078

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP12846665A
Filing Date
Oct 31, 2012
Status
Revoked
Feb 12, 2024
Grant Date
May 22, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANFeb 21, 2020AVIDITY -

Patent Citations (39) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0125023
DESCRIPTIONEP0239400
DESCRIPTIONJPH0159878B
DESCRIPTIONJPH10504970
DESCRIPTIONWO2006106905
DESCRIPTIONWO2006109592
DESCRIPTIONWO2007114325
DESCRIPTIONWO2007147901
DESCRIPTIONWO2009080254
DESCRIPTIONWO2009089004
DESCRIPTIONWO2010129304
DESCRIPTIONWO9201047
DESCRIPTIONWO9203918
DESCRIPTIONWO9220791
DESCRIPTIONWO9306213
DESCRIPTIONWO9311236
DESCRIPTIONWO9312227
DESCRIPTIONWO9319172
DESCRIPTIONWO9402602
DESCRIPTIONWO9501438
DESCRIPTIONWO9515388
DESCRIPTIONWO9515393
DESCRIPTIONWO9602576
DESCRIPTIONWO9627011
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9813388
DESCRIPTIONWO9846777
DESCRIPTIONWO9850431
EXAMINATIONWO2007110205
INTERNATIONAL-SEARCH-REPORTJP2011508604
INTERNATIONAL-SEARCH-REPORTWO2006106905
OPPOSITIONEP2787078
OPPOSITIONUS2010015133
OPPOSITIONWO2006106905
OPPOSITIONWO2009089004
OPPOSITIONWO2012131555
SEARCHEP1870459
SEARCHEP2009101

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- PADLAN E A ET AL, "Antibody Fab assembly: The interface residues between CH1 and CL", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 23, no. 9, doi:10.1016/0161-5890(86)90125-2, ISSN 0161-5890, (19860901), pages 951 - 960, (19860901), XP023786401
OPPOSITION- Declaration by Dr Holliger-
OPPOSITION- Dr Holliger's CV-
OPPOSITION- SANTOS A D, PADLAN E A, "DEVELOPMENT OF MORE EFFICACIOUS ANTIBODIES FOR MEDICAL THERAPY AND DIAGNOSIS", PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY., ACADEMIC PRESS., US, US , (19980101), vol. 60, ISSN 0079-6603, pages 169 - 194, XP009039512-
SEARCH- EDELMAN GM ET AL, "The covalent structure of an entire gammaG immunoglobulin molecule", PROC NATL ACAD SCI U S A, (19690501), vol. 63, no. 1, pages 78 - 85, XP055188533 [X] 3,4,9 * figures 2,3 * [I] 14-16-
SEARCH- JOHNSON GEORGE ET AL, "Kabat Database and its applications: 30 years after the first variability plot", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, (20000101), vol. 28, no. 1, ISSN 0305-1048, pages 214 - 218, XP009132432 [AD] 1-16 * the whole document *-
SEARCH- ZHU ET AL, "REMODELLING DOMAIN INTERFACES TO ENHANCE HETERODIMER FORMATION", PROTEIN SCIENCE, WILEY, US, (19970401), vol. 6, no. 4, ISSN 0961-8368, pages 781 - 788, XP002084764 [AD] 1-16 * abstract * * page 782, column l, paragraph 1 * * page 784, column l, paragraph 2 - column r, paragraph 4 * * Discussion *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents